Q/C Technologies, Inc. Derivative, Fair Value, Net
Q/C Technologies, Inc. (QCLS) had Derivative, Fair Value, Net of $0 as of 2025-06-30, per its 10-Q filed 2025-08-19.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeFairValueOfDerivativeNet · last filed 2026-04-15
- 2025-06-30: Derivative, Fair Value, Net $0.00.
- 2025-03-31: Derivative, Fair Value, Net $0.00.
- 2024-12-31: Derivative, Fair Value, Net $0.00.
- 2024-09-30: Derivative, Fair Value, Net $0.00.
| Period end | Derivative, Fair Value, Net | Derivative, Fair Value, Net as first filed |
|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $0.00 10-K · filed 2026-04-15 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $61.00K 10-K · filed 2024-04-01 | |
| 2023-09-30 | $898.10K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.46M 10-Q · filed 2023-08-14 | |
| 2023-02-21 | $3.15M 10-Q · filed 2025-08-19 | $3.15M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |